search
Back to results

A Combined Nerve Block in Elderly Patients Subjected to Total Hip Replacement

Primary Purpose

Arthropathy of Hip

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
combined nerve block
general anesthesia
Sponsored by
Qinghai University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arthropathy of Hip

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Blood pressure below 160/90 mmHg (1 mm = 0.133 kPa)
  • Hemoglobin > 90 g/L
  • Fasting blood glucose level < 10 mM
  • Preoperative examinations (blood, urine, stool tests, hepatic and renal function, blood coagulation, electrolyte level and electrocardiogram): normal
  • Type I-II in American Society of Anesthesiology (ASA) classification
  • Age > 65 years
  • Of either sex
  • Provision of signed informed consent to participate in the trial

Exclusion Criteria:

  • Severe heart, liver, lung, kidney or hematological system diseases, severe infection or malignant tumor
  • Allergy to anesthetic agents
  • Are taking immunosuppressive agents and/or glucocorticoid
  • Viral infections
  • Mental disorder, dysnoesia, hearing disorder or poor compliance during the anesthesia
  • Alcohol or drug abuse

Sites / Locations

  • Qinghai University Affiliated HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

experimental group

control group

Arm Description

Combined nerve block will be used, involving lower lumbar plexus, sciatic nerve, and paraspinal nerve L1-2.

General anesthesia will be used in this group.

Outcomes

Primary Outcome Measures

Intraoperative serum cortisol concentration
To evaluate intraoperative stress response. The normal serum cortisol concentration is 138-635 nM measured at 8:00 a.m.-10:00 a.m. and 83-359 nM at 4:00 p.m.-6:00 p.m. Greater intraoperative serum cortisol concentration indicates stronger stress response.

Secondary Outcome Measures

Serum cortisol concentration
to evaluate patient's stress response.
Blood glucose level
to evaluate patient's stress response at each time period. The fasting blood glucose in the normal population is 3.61-6.11 mM. Higher fasting blood glucose level indicates stronger stress response .
Incidence of adverse events
These adverse events include upper respiratory tract infection, pulmonary infection, acute atelectasis and acute pulmonary embolism.

Full Information

First Posted
August 19, 2016
Last Updated
August 30, 2016
Sponsor
Qinghai University
search

1. Study Identification

Unique Protocol Identification Number
NCT02884388
Brief Title
A Combined Nerve Block in Elderly Patients Subjected to Total Hip Replacement
Official Title
Effects of a Combined Nerve Block on Intraoperative Stress and Postoperative Immune Function in Elderly Patients Subjected to Total Hip Replacement: Study Protocol for a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2015 (undefined)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Qinghai University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to validate the hypothesis that a combined nerve block produces better outcomes including intraoperative stress, hemorrheological indexes, postoperative immune function, and incidence of postoperative complications than general anesthesia.
Detailed Description
The elderly patients have poor tolerance to anesthesia and total hip replacement because of severe surgical trauma and much blood loss. General anesthesia is a primary anesthesia method used previously for total hip replacement in the elderly and it has many limitations, for example, it can interfere with the physiological function in the elderly patients. The organic function and compensative ability of the elderly are often weakened to varying degrees because of cardiovascular disease, pulmonary disease or diabetes mellitus, thus nociceptive stimuli such as anesthesia and surgery greatly influence the stress. Stress refers to an organism's non-specific reactions to various nociceptive stimuli, i.e., stressors, in which many factors are involved. It can stimulate sympathetic nerves, strengthen the function of hypothalamic-pituitary-adrenal axis, and cause changes in various metabolisms, thereby playing an important role in maintaining intraoperative vital signs and recovering postoperative immune function. Different anesthesia methods produce different effects on organism's immune function. Effects of anesthesia on immune function are closely related to the complications, such as postoperative infection. In addition, the immunity in the elderly is relatively poorer than that in the normal healthy population. Therefore, a rational anesthesia method is of important clinical significance for safe surgery and postoperative recovery in the elderly. A combined nerve block has been reportedly to be more suitable for total hip replacement in the elderly because of its safety and reliability. Previous related studies focused primarily on onset time of anesthesia and postoperative complications. To the best of our knowledge, no studies have been reported on the effect of a combined nerve block on intraoperative stress and postoperative immune function in the elderly patients subjected to total hip replacement. Therefore, this study is innovative in our mind. Adverse events If severe adverse events including any expected or unexpected symptoms occur, information including the data of occurrence, type of adverse events, measures taken related to the treatment of the adverse events will be reported to the project manager and the institutional review board within 24 hours. Data collection, management, analysis and open access Data collection: according to trial design type and requirement, a table will be developed to record trial data. The recorded data will be input into an electronic database using a double-data entry strategy by trained professional staff. Data management: information accuracy will be checked when all recruited patients are followed up. The database will be locked by the researcher in charge and will not be altered. All information relating to this trial will be preserved by Qinghai University Affiliated Hospital, China. Data analysis: The electronic database will be made available to a professional statistician for statistical analysis. An outcome analysis report will be made by the statistician and submitted to the lead researchers. An independent data monitoring committee will supervise and manage the trial data with the goal of ensuring a scientific and stringent trial process, resulting in accurate and complete data. Data open access: Anonymized trial data will be published at http://www.figshare.com. Statistical analysis Statistical analysis will be performed by a statistician using SPSS 19.0 software and will follow the intention-to-treat principle. Normally distributed measurement data will be expressed as a mean, standard deviation, min, and max. Non-normally distributed measurement data will be expressed as a lower quartile (q1), median, and upper quartile (q3). The Mann-Whitney U test will be used to compare fasting blood glucose level, serum cortisol concentration, hemorrheological indexes and immune function-related indices between experimental and control groups. The Mcnemar χ2 test will be used to compare the incidence of adverse events between experimental and control groups, with an accepted significance level of α = 0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthropathy of Hip

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
experimental group
Arm Type
Experimental
Arm Description
Combined nerve block will be used, involving lower lumbar plexus, sciatic nerve, and paraspinal nerve L1-2.
Arm Title
control group
Arm Type
Experimental
Arm Description
General anesthesia will be used in this group.
Intervention Type
Procedure
Intervention Name(s)
combined nerve block
Other Intervention Name(s)
experimental group
Intervention Description
Patients in this group were assigned to receive lower lumbar plexus block, sciatic nerve block, and paraspinal nerve L1-2 block.
Intervention Type
Procedure
Intervention Name(s)
general anesthesia
Other Intervention Name(s)
control group
Intervention Description
Patients in this group were assigned to receive general anesthesia.
Primary Outcome Measure Information:
Title
Intraoperative serum cortisol concentration
Description
To evaluate intraoperative stress response. The normal serum cortisol concentration is 138-635 nM measured at 8:00 a.m.-10:00 a.m. and 83-359 nM at 4:00 p.m.-6:00 p.m. Greater intraoperative serum cortisol concentration indicates stronger stress response.
Time Frame
during surgery
Secondary Outcome Measure Information:
Title
Serum cortisol concentration
Description
to evaluate patient's stress response.
Time Frame
prior to anesthesia, prior to and immediately after surgery
Title
Blood glucose level
Description
to evaluate patient's stress response at each time period. The fasting blood glucose in the normal population is 3.61-6.11 mM. Higher fasting blood glucose level indicates stronger stress response .
Time Frame
prior to anesthesia, prior to, during and immediately after surgery
Title
Incidence of adverse events
Description
These adverse events include upper respiratory tract infection, pulmonary infection, acute atelectasis and acute pulmonary embolism.
Time Frame
1, 3, 7 days and 3 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Blood pressure below 160/90 mmHg (1 mm = 0.133 kPa) Hemoglobin > 90 g/L Fasting blood glucose level < 10 mM Preoperative examinations (blood, urine, stool tests, hepatic and renal function, blood coagulation, electrolyte level and electrocardiogram): normal Type I-II in American Society of Anesthesiology (ASA) classification Age > 65 years Of either sex Provision of signed informed consent to participate in the trial Exclusion Criteria: Severe heart, liver, lung, kidney or hematological system diseases, severe infection or malignant tumor Allergy to anesthetic agents Are taking immunosuppressive agents and/or glucocorticoid Viral infections Mental disorder, dysnoesia, hearing disorder or poor compliance during the anesthesia Alcohol or drug abuse
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Liangde A, Master
Phone
8618009782881
Email
liangdea_qu@sina.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liangde A, Master
Organizational Affiliation
Affiliated Hospital of Qinghai University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Qinghai University Affiliated Hospital
City
Xining
State/Province
Qinghai
ZIP/Postal Code
810001
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Liangde A, Master
Phone
8618009782881
Email
liangdea_qu@sina.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

A Combined Nerve Block in Elderly Patients Subjected to Total Hip Replacement

We'll reach out to this number within 24 hrs